Galenica AG (CH:GALE)
:GALE
GALE Stock Chart & Stats
CHF90.85
-CHF1.55(-1.89%)
At close: 4:00 PM EST
CHF90.85
-CHF1.55(-1.89%)
Day’s Range― - ―
52-Week RangeCHF76.75 - CHF103.00
Previous CloseN/A
Volume39.77K
Average Volume (3M)91.35K
Market Cap
CHF4.53B
Enterprise ValueCHF5.49B
Total Cash (Recent Filing)CHF115.51M
Total Debt (Recent Filing)CHF1.06B
Price to Earnings (P/E)26.9
Beta0.33
Next Earnings
Aug 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.36%
Share Statistics
EPS (TTM)1.86
Shares Outstanding50,000,000
10 Day Avg. Volume70,861
30 Day Avg. Volume91,351
Financial Highlights & Ratios
PEG Ratio-24.67
Price to Book (P/B)3.29
Price to Sales (P/S)1.18
P/FCF Ratio17.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF85.00Price Target Upside-6.44% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering1
EPS Forecast (FY)3.99
Revenue Forecast (FY)CHF4.36B
Bulls Say, Bears Say
Bulls Say
Diversified Business ModelGalenica’s dual model—nationwide wholesale/logistics plus a large pharmacy retail network—creates stable, complementary revenue streams. Vertical exposure to both B2B distribution and consumer retail reduces reliance on a single channel and supports durable cash flow across cycles.
Strong Cash GenerationHigh cash conversion (FCF ~91% of net income) indicates core operations reliably generate cash for reinvestment, dividends and debt service. Consistent positive operating and free cash flow across years supports financial flexibility despite episodic volatility.
Revenue Recovery & Steady ProfitabilityAfter a 2023 dip, revenue growth resumed in 2024–2025 and margins remained broadly stable. This rebound suggests the business can restore top-line momentum while sustaining mid-single-digit operating margins, supporting medium-term earnings resilience.
Bears Say
Rising LeverageMaterial increase in leverage reduces financial flexibility and raises sensitivity to interest-rate or earnings shocks. For a distribution business with working-capital needs, higher debt can constrain strategic options, increase refinancing risk and magnify profit volatility.
Margin And Cash-flow VolatilityNotable swings in gross margins and intermittent declines in free cash flow undermine earnings visibility. For a business reliant on distribution and retail mix, such variability complicates planning, raises forecasting risk and can strain ability to fund growth consistently.
Modest Operating MarginsRelatively low margins limit the company’s buffer against cost inflation and competitive pressure. In a low-margin distribution/retail model, constrained profitability reduces capacity to invest in differentiation or absorb adverse trading conditions without eroding returns.
Galenica AG News
GALE FAQ
What was Galenica AG’s price range in the past 12 months?
Galenica AG lowest stock price was CHF76.75 and its highest was CHF103.00 in the past 12 months.
What is Galenica AG’s market cap?
Galenica AG’s market cap is CHF4.53B.
When is Galenica AG’s upcoming earnings report date?
Galenica AG’s upcoming earnings report date is Aug 11, 2026 which is in 131 days.
How were Galenica AG’s earnings last quarter?
Galenica AG released its earnings results on Mar 10, 2026. The company reported CHF1.863 earnings per share for the quarter, missing the consensus estimate of CHF1.99 by -CHF0.127.
Is Galenica AG overvalued?
According to Wall Street analysts Galenica AG’s price is currently Overvalued.
Does Galenica AG pay dividends?
Galenica AG pays a Annually dividend of CHF2.3 which represents an annual dividend yield of 2.36%. See more information on Galenica AG dividends here
What is Galenica AG’s EPS estimate?
Galenica AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Galenica AG have?
Galenica AG has 50,000,000 shares outstanding.
What happened to Galenica AG’s price movement after its last earnings report?
Galenica AG reported an EPS of CHF1.863 in its last earnings report, missing expectations of CHF1.99. Following the earnings report the stock price went up 0.745%.
Which hedge fund is a major shareholder of Galenica AG?
Currently, no hedge funds are holding shares in CH:GALE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Galenica AG
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates 520 pharmacies, including 368 owned pharmacies and 152 partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers logistics and IT services, and master data system for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.
GALE Stock 12 Month Forecast
Average Price Target
CHF85.00
▼(-6.44% Downside)
Technical Analysis
Bachem Holding AG
―
Medacta Group SA
―
Siegfried Holding AG
―
Tecan Group AG
―
Ypsomed Holding AG
―
Options Prices
Currently, No data available
---